CATALYST PHARMACEU earnings per share and revenue

CN2 earnings per share for the last quarter are 0.40 CHF whereas the estimation was 0.30 CHF which accounts for 32.35% surprise. Company revenue for the same period amounts to 125.17 M CHF despite the estimated figure of 116.40 M CHF. Estimated earnings per share for the next quarter are 0.32 CHF, and revenue is expected to reach 117.77 M CHF. Also watch annual changes over time to get a bigger picture of CN2 earnings per share and revenue dynamics.